Terms: = Uterine cancer AND CYLD, CYLD1, 1540, ENSG00000083799, USPL2, KIAA0849, CYLDI, CDMT, HSPC057, FLJ31664, FLJ20180, EAC AND Diagnosis
28 results:
1. Clinical and multiparametric MRI features for differentiating uterine carcinosarcoma from endometrioid adenocarcinoma.
Chen X; Guo Q; Chen X; Zheng W; Kang Y; Cao D
BMC Med Imaging; 2024 Feb; 24(1):48. PubMed ID: 38373912
[TBL] [Abstract] [Full Text] [Related]
2. Endometrioid adenocarcinoma: combined multiparametric MRI and tumour marker HE4 to evaluate tumour grade and lymphovascular space invasion.
Yue XN; He XY; Wu JJ; Fan W; Zhang HJ; Wang CW
Clin Radiol; 2023 Aug; 78(8):e574-e581. PubMed ID: 37183140
[TBL] [Abstract] [Full Text] [Related]
3. 3D multifrequency magnetic resonance elastography in distinguishing endometrial and cervical adenocarcinoma.
Long L; Liu M; Deng X; Cao M; Zhang J; Lan X; Zhang J
Magn Reson Imaging; 2023 Oct; 102():62-68. PubMed ID: 37146780
[TBL] [Abstract] [Full Text] [Related]
4. Using Silva pattern system to predict prognosis and plan treatment of invasive endocervical adenocarcinoma: a single-center retrospective analysis.
Li X; Pang S; Shen Y; Qu P
BMC Womens Health; 2022 Dec; 22(1):488. PubMed ID: 36460984
[TBL] [Abstract] [Full Text] [Related]
5. Silva cumulative score and its relationship with prognosis in Endocervical adenocarcinoma.
Li Y; Jia M; Cao L; Yu J; Gao H; Sun PL
BMC Cancer; 2022 Nov; 22(1):1172. PubMed ID: 36376880
[TBL] [Abstract] [Full Text] [Related]
6. The effect of preserving pregnancy in cervical cancer diagnosed during pregnancy: a retrospective study.
He Z; Xie C; Qi X; Hu Z; He Y
BMC Womens Health; 2022 Jul; 22(1):314. PubMed ID: 35879712
[TBL] [Abstract] [Full Text] [Related]
7. Clinical characteristic and prognostic factors in high-grade endometrial neuroendocrine carcinoma.
Zhang Z; Wang J; Wu X; Liu Y; Xi X
J Obstet Gynaecol Res; 2022 Aug; 48(8):2180-2188. PubMed ID: 35778826
[TBL] [Abstract] [Full Text] [Related]
8. Endocervical Cytology: Inter- and Intra-Observer Variability in Conventional Pap Smears.
Pulkkinen J; Huhtala H; Krogerus LA; Hollmén S; Laurila M; Kholová I
Acta Cytol; 2022; 66(3):206-215. PubMed ID: 35226896
[TBL] [Abstract] [Full Text] [Related]
9. Endocervical neoplasia: Pathologic updates in diagnosis and prognosis.
Rivera-Colón G; Zheng W
Semin Diagn Pathol; 2022 May; 39(3):213-227. PubMed ID: 34953647
[TBL] [Abstract] [Full Text] [Related]
10. Sentinel lymph node biopsy at robotic-assisted hysterectomy for atypical hyperplasia and endometrial cancer.
El-Achi V; Burling M; Al-Aker M
J Robot Surg; 2022 Oct; 16(5):1111-1115. PubMed ID: 34855134
[TBL] [Abstract] [Full Text] [Related]
11. Identification of clinical trait-related small RNA biomarkers with weighted gene co-expression network analysis for personalized medicine in endocervical adenocarcinoma.
Shi Z; Qu X; Guo C; Zhang L; Peng C; Xie Z; Hua K; Qiu J
Aging (Albany NY); 2021 Sep; 13(18):22361-22374. PubMed ID: 34542422
[TBL] [Abstract] [Full Text] [Related]
12. Online Training and Self-assessment in the Histopathologic Classification of Endocervical Adenocarcinoma and diagnosis of Pattern of Invasion: Evaluation of Participant Performance.
Park KJ; Cabrero IA; Fadare O; Hoang L; Kiyokawa T; Oliva E; Parra-Herran C; Rabban JT; Roma A; Singh N; Soslow R; Stolnicu S; Huvila J; Leung S; Gilks CB
Int J Gynecol Pathol; 2021 Mar; 40(Suppl 1):S14-S23. PubMed ID: 33570861
[TBL] [Abstract] [Full Text] [Related]
13. Feasibility of intravoxel incoherent motion diffusion-weighted imaging in distinguishing adenocarcinoma originated from uterine corpus or cervix.
Zhang Q; Ouyang H; Ye F; Song Y; Xie L; Zhao X; Yu X
Abdom Radiol (NY); 2021 Feb; 46(2):732-744. PubMed ID: 32671441
[TBL] [Abstract] [Full Text] [Related]
14. Cytology and curetting diagnosis of endocervical adenocarcinoma.
Bruehl FK; Dyhdalo KS; Hou Y; Clapacs E; Przybycin CG; Reynolds JP
J Am Soc Cytopathol; 2020; 9(6):556-562. PubMed ID: 32624383
[TBL] [Abstract] [Full Text] [Related]
15. Challenges and controversies in the conservative management of uterine and ovarian cancer.
Janda M; McGrath S; Obermair A
Best Pract Res Clin Obstet Gynaecol; 2019 Feb; 55():93-108. PubMed ID: 30243603
[TBL] [Abstract] [Full Text] [Related]
16. Endometrioid Adenocarcinoma Arising in a Paratubal Cyst: A Case Report and Review of the Literature.
Chang C; Matsuo K; Mhawech-Fauceglia P
Appl Immunohistochem Mol Morphol; 2017 Mar; 25(3):e21-e24. PubMed ID: 28277338
[TBL] [Abstract] [Full Text] [Related]
17. Abnormal mismatch repair and other clinicopathologic predictors of poor response to progestin treatment in young women with endometrial complex atypical hyperplasia and well-differentiated endometrial adenocarcinoma: a consecutive case series.
Zakhour M; Cohen JG; Gibson A; Walts AE; Karimian B; Baltayan A; Aoyama C; Garcia L; Dhaliwal SK; Elashoff D; Amneus M; Walsh C
BJOG; 2017 Sep; 124(10):1576-1583. PubMed ID: 28128512
[TBL] [Abstract] [Full Text] [Related]
18. Patterns of Invasion of Cervical Adenocarcinoma as Predicators of Outcome.
Roma AA
Adv Anat Pathol; 2015 Nov; 22(6):345-54. PubMed ID: 26452210
[TBL] [Abstract] [Full Text] [Related]
19. SOX-2, but not Oct4, is highly expressed in early-stage endometrial adenocarcinoma and is related to tumour grading.
Pityński K; Banas T; Pietrus M; Milian-Ciesielska K; Ludwin A; Okon K
Int J Clin Exp Pathol; 2015; 8(7):8189-98. PubMed ID: 26339387
[TBL] [Abstract] [Full Text] [Related]
20. ER+ /PR+ /TFF3+ /IMP3- immunoprofile distinguishes endometrioid from serous and clear cell carcinomas of the endometrium: a study of 401 cases.
Mhawech-Fauceglia P; Yan L; Liu S; Pejovic T
Histopathology; 2013 Jun; 62(7):976-85. PubMed ID: 23570281
[TBL] [Abstract] [Full Text] [Related]
[Next]
